Subscribe
25 July 2024NewsAmericasLiz Hockley

Panitch Schwarze brings in molecular biologist

Scientist and patent attorney joins boutique IP firm in Philadelphia | Former in-house counsel brings expertise representing variety of life sciences clients.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
IP firm lands attorney with ‘deep experience’ in research and innovation
28 November 2023   With his ‘extensive’ scientific background and links to Nobel-Prize-winning inventions, Christopher North brings a wealth of experience and knowledge to Panitch Schwarze’s patent team.
Careers
Knobbe Martens partner joins Snell & Wilmer’s Orange County IP practice
4 July 2024   New partner has expertise across life sciences, biotech and medtech | Patent attorney spent over 15 years at Knobbe Martens.
Big Pharma
Foley Hoag strengthens biotech team with Fenwick & West patent expert
13 June 2024   New counsel previously worked in-house at major pharmaceutical firm | Ex-Fenwick & West attorney has advised clients in areas including gene editing and antibodies.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

article
IP firm lands attorney with ‘deep experience’ in research and innovation
28 November 2023   With his ‘extensive’ scientific background and links to Nobel-Prize-winning inventions, Christopher North brings a wealth of experience and knowledge to Panitch Schwarze’s patent team.
Careers
Knobbe Martens partner joins Snell & Wilmer’s Orange County IP practice
4 July 2024   New partner has expertise across life sciences, biotech and medtech | Patent attorney spent over 15 years at Knobbe Martens.
Big Pharma
Foley Hoag strengthens biotech team with Fenwick & West patent expert
13 June 2024   New counsel previously worked in-house at major pharmaceutical firm | Ex-Fenwick & West attorney has advised clients in areas including gene editing and antibodies.

More on this story

article
IP firm lands attorney with ‘deep experience’ in research and innovation
28 November 2023   With his ‘extensive’ scientific background and links to Nobel-Prize-winning inventions, Christopher North brings a wealth of experience and knowledge to Panitch Schwarze’s patent team.
Careers
Knobbe Martens partner joins Snell & Wilmer’s Orange County IP practice
4 July 2024   New partner has expertise across life sciences, biotech and medtech | Patent attorney spent over 15 years at Knobbe Martens.
Big Pharma
Foley Hoag strengthens biotech team with Fenwick & West patent expert
13 June 2024   New counsel previously worked in-house at major pharmaceutical firm | Ex-Fenwick & West attorney has advised clients in areas including gene editing and antibodies.

More features

Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
Novo Nordisk files fresh lawsuits to intercept Wegovy generics
HLK adds CRISPR specialist as partner
UPC delivers first 'imminent infringement' decision in biosimilar dispute